David Flacks has been AFT's chair since before the company listed. (Image: Supplied)AFT Pharmaceuticals chair David Flacks will step down within the next 12 months. In documents released to the NZX before the company's annual general meeting on Friday, Flacks said he would not seek re-election at the next annual meeting, having served 12 years as chair. He will remain in the role until a successor is appointed and assist with the transition. Flacks said it was his pleasure to report a year of record results for AFT Pharmaceuticals, with double-digit revenue growth across all territories, record earning...